These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20387287)

  • 21. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications].
    Kupryś-Lipińska I; Kuna P
    Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
    Solèr M; Matz J; Townley R; Buhl R; O'Brien J; Fox H; Thirlwell J; Gupta N; Della Cioppa G
    Eur Respir J; 2001 Aug; 18(2):254-61. PubMed ID: 11529281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omalizumab improves asthma-related quality of life in children with allergic asthma.
    Lemanske RF; Nayak A; McAlary M; Everhard F; Fowler-Taylor A; Gupta N
    Pediatrics; 2002 Nov; 110(5):e55. PubMed ID: 12415061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omalizumab and other new drug therapies occupy a small space in asthma disease management.
    Curtiss FR
    J Manag Care Pharm; 2009 Apr; 15(3):289-93. PubMed ID: 19326961
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunological intervention with anti-immunoglobulin-E antibody to prevent asthma exacerbations.
    Chanez P
    Eur Respir J; 2001 Aug; 18(2):249-50. PubMed ID: 11529279
    [No Abstract]   [Full Text] [Related]  

  • 26. [Better management of patients with difficult asthma].
    Humbert M
    Presse Med; 2006 Oct; 35(10 Pt 2):1492-4. PubMed ID: 17028512
    [No Abstract]   [Full Text] [Related]  

  • 27. [Analysis of asthma control and quality of life in severe allergic asthmatics under treatment with anti-IgE, omalizumab].
    Pacheco-Galván A; Hinojosa-Macías M; Hurtado-Barbudo B; González-Cervera J; Sueiro-Bendito A
    Med Clin (Barc); 2009 Oct; 133(12):460-3. PubMed ID: 19775710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-IgE for chronic asthma in adults and children.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of omalizumab in the treatment of severe allergic asthma.
    Chapman KR; Cartier A; Hébert J; McIvor RA; Schellenberg RR
    Can Respir J; 2006; 13 Suppl B(Suppl B):1B-9B. PubMed ID: 16909166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omalizumab: new drug. Asthma: too many unknowns for an anti-IgE.
    Prescrire Int; 2007 Oct; 16(91):179-82. PubMed ID: 17926440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summaries for patients. Omalizumab therapy for patients with severe asthma.
    Ann Intern Med; 2011 May; 154(9):I28. PubMed ID: 21536934
    [No Abstract]   [Full Text] [Related]  

  • 33. How do we interpret the data supporting the use of omalizumab for severe asthma?
    Lavietes MH
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):335-6. PubMed ID: 25256024
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduction of the total IgE Level by omalizumab in children and adolescents.
    Slavin RG; Jimenez P
    J Asthma; 2009 Feb; 46(1):102-3. PubMed ID: 19191148
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
    Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omalizumab: a review of its use in the treatment of allergic asthma.
    Plosker GL; Keam SJ
    BioDrugs; 2008; 22(3):189-204. PubMed ID: 18481901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-IgE and chemotherapy: a critical appraisal of treatment options for severe asthma.
    Walters EH; Walters JA; Wood-Baker R
    Expert Opin Pharmacother; 2007 Apr; 8(5):585-92. PubMed ID: 17376014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A
    Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IgE for chronic asthma.
    Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003559. PubMed ID: 12917972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of omalizumab in asthma.
    Tan RA; Corren J
    Expert Opin Drug Saf; 2011 May; 10(3):463-71. PubMed ID: 21401438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.